Effects of Venlafaxine on Blood Pressure: A Meta-Analysis of Original Data From 3744 Depressed Patients

文拉法辛 血压 安慰剂 丙咪嗪 医学 剂量 抗抑郁药 盐酸文拉法辛 麻醉 阿替洛尔 萧条(经济学) 内科学 经济 宏观经济学 海马体 替代医学 病理
作者
Michael E. Thase
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:59 (10): 502-508 被引量:367
标识
DOI:10.4088/jcp.v59n1002
摘要

BACKGROUND: Venlafaxine hydrochloride, a structurally novel antidepressant, is also the first nontricyclic serotonin/norepinephrine reuptake inhibitor. Although venlafaxine has an overall side effect and safety profile that is comparable to other newer antidepressants, it can cause both transient and sustained elevations of supine diastolic blood pressure (SDBP), probably the result of noradrenergic potentiation. METHOD: Presented here is a meta-analysis of original data on blood pressure, using both random effects and a multivariate survival analyses. The sample consisted of 3744 patients with major depression who were studied in controlled clinical trials comparing venlafaxine with imipramine and/or placebo. Patients were treated for 6 weeks of acute phase therapy; some responders received up to 1 year of continuation phase therapy. RESULTS: Venlafaxine and imipramine were associated with small, but statistically significant, increases in SDBP during acute phase therapy. When compared with imipramine and placebo, venlafaxine was also associated with a greater proportion of persistent elevations of SDBP during continuation therapy. The effect of venlafaxine was highly dose dependent, and the incidence of elevated SDBP was statistically and clinically significant only at dosages above 300 mg/day. Venlafaxine did not adversely affect the control of blood pressure for patients with preexisting high blood pressure or elevated baseline values. CONCLUSION: Venlafaxine has a dose-dependent effect on SDBP that is clinically significant at high dosages. Concern about blood pressure effects should not deter first-line use of this effective antidepressant, although more extensive studies of patients with cardiovascular diseases are still necessary.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
好吃懒做发布了新的文献求助10
刚刚
1秒前
sunshine发布了新的文献求助10
1秒前
魔幻凡儿发布了新的文献求助10
2秒前
一两二两三两斤完成签到,获得积分10
2秒前
NexusExplorer的应助被zyw采纳,获得10
2秒前
科研通AI6.3的应助被Linda采纳,获得10
3秒前
molihuakai的应助被jyzx采纳,获得10
3秒前
gg发布了新的文献求助10
3秒前
赘婿的应助被冷酷的安珊采纳,获得10
3秒前
HR完成签到,获得积分10
3秒前
3秒前
充电宝的应助被niiiiii采纳,获得10
4秒前
4秒前
4秒前
4秒前
Yvette发布了新的文献求助10
5秒前
ZJ发布了新的文献求助10
5秒前
结实无敌发布了新的文献求助10
5秒前
surain发布了新的文献求助10
6秒前
IY发布了新的文献求助30
6秒前
cy发布了新的文献求助10
7秒前
chen发布了新的文献求助10
7秒前
7秒前
风吹麦浪的应助被Tuniverse_采纳,获得10
7秒前
Hello的应助被lixiaobai采纳,获得10
7秒前
晚风发布了新的文献求助10
8秒前
mzk完成签到,获得积分10
8秒前
婧婧发布了新的文献求助20
8秒前
8秒前
8秒前
景哉发布了新的文献求助10
9秒前
gshaoooo完成签到,获得积分10
9秒前
机智飞丹完成签到,获得积分20
9秒前
9秒前
jyzx完成签到 ,获得积分10
9秒前
10秒前
10秒前
yl发布了新的文献求助10
10秒前
嘻嘻哈哈的应助被插线板采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182602
求助须知:如何正确求助?哪些是违规求助? 9572033
关于积分的说明 21821767
捐赠科研通 7779061
什么是DOI,文献DOI怎么找? 3433684
关于科研通互助平台的介绍 2557863
邀请新用户注册赠送积分活动 2479732